Taylor-Wharton泰來華頓和Worthington Industries并購，產(chǎn)品型號并未改變，但品牌標識做了轉(zhuǎn)變，而泰萊華頓的原產(chǎn)品線和新產(chǎn)品線的并存，導致有2-3年的產(chǎn)品標識過渡期，相同的型號，相同的品質(zhì)，不同的品牌標識并不影響客戶使用體驗。
美國Taylor Wharton泰來華頓液氮罐是美國歷史zui悠久的，仍在運營的金屬制品公司，其歷史可以追溯到1742年。早期的產(chǎn)品包括有給喬治華盛頓*生產(chǎn)的炮彈; 美國登月宇航員背負設(shè)備中所用的罐體及管道。其生產(chǎn)廠部位于Alabama阿拉巴馬州的Theodore西奧多。 CryoScience深冷科技部門早在1957就開始生產(chǎn)液氮生物深低溫容器。經(jīng)過一系列的技術(shù)發(fā)展和時間的檢驗，現(xiàn)在產(chǎn)品系列涵蓋深低溫氣相/液相液氮存儲罐，干式液氮運輸罐，液氮杜瓦補充罐等所有行業(yè)需求類別。
Worthington Industries (沃辛頓工業(yè)WI)，總部在Ohio俄亥俄州的Columbus哥倫布。公司成立于1955年，發(fā)展卻十分迅猛。現(xiàn)在是市值40億美金的紐約上市公司 (NYSE WOR) 。是的平軋鋼和壓力容器等工業(yè)產(chǎn)品制造商，擁有上萬名員工，5000多個客戶，83個分支機構(gòu)，遍布11個國家。
2015年底, Worthington Industries完成了對Taylor-Wharton CryoScience的并購。現(xiàn)在經(jīng)過兩者強強聯(lián)合，成立歷史背景悠久，科技力量先進和資金實力雄厚的WORTHINGTON INDUSTRIES LIFE SCIENCES部門，現(xiàn)邀您一起加入生命科學探索之旅。
附，WI并購TW*公告
OVEMBER 23, 2015
WORTHINGTON TO ACQUIRE TAYLOR WHARTON CRYOSCIENCE BUSINESS
COLUMBUS, OH – November 23, 2015 - Worthington Industries, Inc. (NYSE: WOR) announced today that its Cryogenics business in the Pressure Cylinders segment is purchasing the assets of the global CryoScience business of Taylor Wharton, including a manufacturing facility in Theodore, Ala. Worthington will also acquire certain other inlectual property and manufacturing assets of Taylor Wharton focused on the cryogenic industrial and LNG markets. The asset purchase is being made pursuant to the Chapter 11 bankruptcy proceedings of Taylor Wharton for $33.25 million and is expected to close on or about Dec. 7.
The CryoScience product line includes cryogenic biologic specimen storage, dewars/shippers, controls and data management solutions for global biomedical research and development, healthcare, bio-banking, pharmaceutical, biotechnology and animal husbandry markets. The business also distributes products through warehouses located in Germany and Australia.
“This purchase extends our cryogenic capabilities into new, global end markets in life science and healthcare,” said Sean Murray, general manager of Worthington’s Cryogenics business. “Taylor Wharton began manufacturing its CryoScience product in 1957 and has developed a robust portfolio of quality products and a strong distribution network in the bioscience space, which we plan to grow. We are also excited about the U.S. manufacturing platform the Alabama facility affords us as we grow in cryogenic industrial gas and LNG.”
Worthington plans to leverage the manufacturing assets of the Theodore, Ala., facility to produce hydrogen, industrial gas and LNG cryogenic transport trailers that are currently being produced in its Boston facility (formerly James Russell Engineering), and eventually move all transport trailer production to Alabama. In the future, this facility could also provide industrial and LNG products such as bulk, microbulk and engineered systems for gas and liquid applications in markets including energy production, industrial fabrication and manufacturing, and hydrogen distribution.
About Worthington Industries
Worthington Industries is a leading global diversified metals manufacturing company with 2015 fiscal year sales of $3.4 billion. Headquartered in Columbus, Ohio, Worthington is North America’s premier value-added steel processor providing customers with wide ranging capabilities, products and services for a variety of markets including automotive, construction and agriculture; a global leader in manufacturing pressure cylinders for industrial gas and cryogenic applications, CNG and LNG storage, transportation and alternative fuel tanks, oil and gas equipment, and brand consumer products for camping, grilling, hand torch solutions and helium balloon kits; and a manufacturer of operator cabs for heavy industrial equipment; laser welded blanks for light weighting applications; automotive racking solutions; and through joint ventures, complete ceiling grid solutions; automotive tooling and stampings; and steel framing for commercial construction. Worthington employs approximay 10,000 people and operates 83 facilities in 11 countries.
Safe Harbor Statement
The Company wishes to take advantage of the Safe Harbor provisions included in the Private Securities Litigation Reform Act of 1995 (the “Act"). Statements by the Company relating to its ability to increase market participation, expand and integrate capacity, increase efficiencies and reduce lead time, achieve growth in general and in specific markets, and other statements which are not historical information constitute "forward looking statements" within the meaning of the Act. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected. Factors that could cause actual results to differ materially include risks described from time to time in the Company's filings with the Securities and Exchange Commission.
